Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

NCT00673829 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Funding

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Gene Modified T Cells
BIOLOGICAL: Gene Modified T Cells and Interleukin 2

Sponsor

Roger Williams Medical Center